Translate this page into:
Biologically active diorganotin(IV) complexes of N-(2-hydroxy-3-isopropyl-6-methyl benzyl) glycine
⁎Corresponding author. Tel.: +91 9412042324. amanrobina@yahoo.com (Robina Aman)
-
Received: ,
Accepted: ,
This article was originally published by Elsevier and was migrated to Scientific Scholar after the change of Publisher.
Peer review under responsibility of King Saud University.

Abstract
A new series of diorganotin(IV) complexes of general formula [Ph2Sn(OPri)(Hhbgl)] (1), [Ph2Sn(Hhbgl)2] (2), [Bu2Sn(OPri)(Hhbgl)] (3), [Bu2Sn(Hhbgl)2] (4), [Me2Sn(OPri)(Hhbgl)] (5), and [Me2Sn(Hhbgl)2] (6) [where H2hbgl = N-(2-hydroxy-3-isopropyl-6-methyl benzyl) glycine] were synthesized by reacting diorganotin(IV) chloride with the ligand, with the aid of sodium iso-propoxide in appropriate stoichiometric ratios (1:1 and 1:2). All the six complexes were tested in vitro for their antibacterial activity against Gram-positive bacteria namely, Staphylococcus aureus MTCC 96, Bacillus subtilis MTCC 121 and two Gram-negative bacteria namely, Escherichia coli MTCC 1652 and Pseudomonas aeruginosa MTCC 741 and in vitro antifungal activity against three pathogenic fungal strains namely, Aspergillus niger, Aspergillus flavus and Penicillium sp.
Keywords
Organotin complexes
Spectroscopic studies
Antifungal activity
Antibacterial activity
- H2hbgl
-
N-(2-hydroxy-3-isopropyl-6-methyl benzyl) glycine
- NaOPri
-
sodium isopropoxide
- Ph2Sn(OPri)2
-
diphenyltin(IV) diisopropoxide
- Bu2Sn(OPri)2
-
dibutyltin(IV) diisopropoxide
- Me2Sn(OPri)2
-
dimethyltin(IV) diisopropoxide
- Ph
-
phenyl
- Bu
-
butyl
- Me
-
methyl
- DMSO
-
dimethylsulphoxide
- MIC
-
minimum inhibitory concentration
- SDA
-
Sabouraud dextrose agar
Abbreviations
1 Introduction
The use of organotin complexes has risen over the last thirty years due to their industrial, medicinal and agricultural applications (Smith, 1997). Since years, organotin(IV) complexes and their derivatives received considerable attention due to their potential and beneficial use in a wide range of biological field (Li et al., 2011; Matela and Aman, 2012; Molter et al., 2012; Nath and Saini, 2011; Torres et al., 2011). Organotin(IV) complexes, having the carboxylate group, show interesting tin chemistry with different coordination spheres at tin atom. Generally five- and six coordination numbers are observed in diorganotin(IV) complexes (Azadmeher et al., 2008; Amini et al., 2009; Amini et al., 2007). While seven coordinated diorganotin(IV) complexes are also observed with mono- and bidentate bonding of the carboxylate group (Salam et al., 2012; Azadmeher et al., 2008).
The biological activity of organotin(IV) complexes is greatly influenced by the geometrical structure and the coordination number of the tin atom. In general, triorganotin(IV) complexes show a stronger biological activity than their di- and mono-organotin(IV) complexes (Demertzi et al., 2009; Rehman et al., 2007). Recent researches across the globe, signify the importance of organotin(IV) complexes in biological activities. A number of studies have been done on antibacterial and antifungal activities of diorganotin(IV) complexes (Saeed et al., 2010; Rehman et al., 2007). Recent years, organotin(IV) complexes also display significant antitumour activity (Alama et al., 2009; Casas et al., 2008; Sun et al., 2011). A promising pharmacological activity such as antiproliferative and antituberculosis activities is investigated by Demertzi et al. (2009). Recently, a luminescent property of organotin(IV) complexes is also observed by Torres et al. (2010). Therefore, the importance of the biological properties and the structure of organotin(IV) complexes has stimulated the study of tin chemistry. Synthesis and biological activities of tin- and triorganotin(IV) complexes of N-(2-hydroxy-3-isopropyl-6-methyl benzyl) glycine have been reported in the previous work (Matela et al., 2013). In the present investigation we have synthesized diorganotin(IV) complexes of N-(2-hydroxy-3-isopropyl-6-methyl benzyl) glycine and studied their biological activities against various bacterial and fungal strains.
2 Materials and methods
All the reagents, viz., diphenyltin(IV) dichloride (Alfa Aesar), dibutyltin(IV) dichloride (Alfa Aesar), dimethyltin(IV) dichloride (Merck) and thymol (sigma–aldrich) were used as received. All the chemicals and solvents used, were dried and purified by standard methods, and moisture was excluded from the glass apparatus using CaCl2 drying tubes. The melting points were determined in open capillaries with electronic melting point apparatus. C, H and N analyses of ligand and complexes were carried on a VarioEL, CHNS elemental analyser. The tin content in the synthesized complexes was determined gravimetrically as SnO2. Infrared spectra of the solid compounds were recorded on a Perkin–Elmer 1600 series FT-IR spectrophotometer in the range of 4000–500 cm− from KBr discs and 500–200 from CsI discs. 1H NMR spectra were recorded on a Bruker Avance II 400 NMR at the Sophisticated Analytical Instrument Facility (SAIF), Punjab University, Chandigarh, India, using DMSO or MeOD as a solvent and TMS as the internal standard. The Conductivity Measurement was performed using a conductometer EcoTestr EC Low in DMSO having 10−3 M at room temperature.
2.1 Synthesis of ligand [H2hbgl]
An equimolar mixture of thymol (11.86 g, 0.05 mol), glycine (3.75 g, 0.05 mol), and sodium acetate crystals (6.8 g, 0.05 mol) was dissolved in glacial acetic acid (25 ml). Formalin solution (37% (w/v); 4.05 ml) was added to it drop wise with stirring and the contents were heated at 60–80 °C, till a viscous mass was obtained. The viscous mass was then poured drop wise with brisk stirring into an excess of water. The thus obtained crude product was purified by dissolving it in a requisite quantity of ca. 7 M sodium hydroxide solution followed by its reprecipitation by 6 M hydrochloric acid. It was further purified by recrystallization from ethanol.
Yield: 9.5 g; colour: yellow; m.p. 70 °C; Anal. Calculated for C13H19NO3: C 65.74%, H 8.00%, N 6.04%; Found: C 65.84%, H 8.10%, N 5.80%; IR (KBr/CsI, cm−1): 3390 ν(–OH), 3056 ν(C–H), 2956, 2856 νas(C–H)/νs(C–H), 1582 νas(COO), 1413 νs(COO); 1H NMR (DMSO, ppm): δ 6.50 (d, 1H, J = 7.8 Hz, Ar–H), δ 6.90 (d, 1H, J = 8 Hz, Ar–H), δ 8.38 (s, 1H, phenolic –OH), δ 7.15 (br, 1H, –NH), δ 2.13 (s, 3H, –CH3), δ 1.81 (s, 2H, Ar–CH2–), δ 3.10 (s, 2H, –CH2–), δ 1.12 (d, 6H, J = 6.9 Hz, –CH(CH3)2); ESI-MS m/z (relative abundance, %): [C13H19NO3]+ 237.9 (48%), [C11H15O]+ 163.1 (30%).
2.2 Synthesis of complexes
2.2.1 [Ph2Sn(OPri)(Hhbgl)] (1)
The solution of diphenyltin(IV) diisopropoxide (1.955 g, 0.005 mol) and H2hbgl (1.067 g, 0.0045 mol) was refluxed in benzene (30 ml) for 8–10 h at 95–100°. The complex, [Ph2Sn(OPri)(Hhbgl)], isolated as a yellow colour solid, was purified by recrystallization from alcohol at room temperature and dried under reduced pressure.
Yield: 1.746 g; colour: yellowish brown; m.p. >300 °C; Molar conductance: 30 μS cm−1; elemental analysis calculated for C28H35NO4Sn: C 59.12%, H 6.16%, N 2.46%, Sn 20.89%; Found: C 59.16%, H 6.20%, N 2.40%, Sn 20.92%; Isopropanol in azeotrope calculated: 0.299 g; Found: 0.270 g.
IR (νmax, cm−1; in KBr): 3405 ν(OH), 3055 ν(C–H), 2959, 2872 νas(C–H)/νs(C–H), 1639 νas(COO), 1416 νs(COO), Δν: 223, 1077, 1028ν(C–O) Sn, 1220 ν(C–O), 551 ν(Sn–O), 269, 228 νas(Sn–C)/νs(Sn–C).
1H NMR (DMSO, ppm): δ 7.29–7.86 (m, 12H, Ar–H and Sn–C6H5), δ 8.06 (s, 1H, phenolic –OH), δ 6.9 (br/s, 1H, –NH), δ 2.10 (s, 3H, –CH3), δ 1.09 (d, 3H, J = 4 Hz, –CH(CH3)2), δ 1.04 (d, 3H, J = 4.4 Hz, –CH(CH3)2).
2.2.2 [Ph2Sn(Hhbgl)2] (2)
Complex 2 was prepared in the similar way as complex 1 using diphenyltin(IV) diisopropoxide (1.955 g, 0.005 mol) and H2hbgl (2.135 g, 0.009 mol).
Yield: 2.288 g; colour: cream; m.p. >300 °C; Molar conductance: 22 μS cm−1; elemental analysis calculated for C38H46N2O6Sn: C 61.17%, H 6.17%, N 3.76%, Sn 15.92%; Found: C 61.20%, H 6.21%, N 3.72%, Sn 15.98%; Isopropanol in azeotrope calculated: 0.598 g; Found: 0.540 g.
IR (νmax, cm−1; in KBr): 3406 ν(OH), 3056 ν(C–H), 2959, 2863 νas(C–H)/νs(C–H), 1639 νas(COO), 1413 νs(COO), Δν: 226, 1081, 1022 ν(C–O) Sn, 1221 ν(C–O), 570 ν(Sn–O), 281, 222 νas(Sn–C)/νs(Sn–C), 441 ν(Sn ← N).
1H NMR (DMSO, ppm): δ 6.58–7.86 (m, 14H, Ar–H and Sn–C6H5), δ 8.11 (s, 2H, phenolic –OH), δ 6.8 (br/s, 2H, –NH), δ 2.10 (s, 6H, CH3), δ 1.14 (d, 6H, J = 6.8 Hz, –CH(CH3)2), δ 1.05 (d, 6H, J = 7.2 Hz, –CH(CH3)2).
2.2.3 [Bu2Sn(OPri)(Hhbgl)] (3)
Complex 3 was prepared in the similar way as complex 1 using dibutyltin(IV) diisopropoxide (1.754 g, 0.005 mol) and H2hbgl (1.067 g, 0.0045 mol).
Yield: 1.593 g; colour: light yellow; m.p. >300 °C; Molar conductance: 25 μS cm−1, elemental analysis calculated for C24H43NO4Sn: C 54.51%, H 8.14%, N 2.65%, Sn 22.47%; Found: C 54.56%, H 8.18%, N 2.60%, Sn 22.50%; Isopropanol in azeotrope calculated: 0.299 g; Found: 0.269 g.
IR (νmax, cm−1; in KBr): 3417 ν(OH), 2956 cm−1, 2862 νas(C–H)/νs(C–H), 1602 νas(COO), 1412 νs(COO), Δν: 190, 1071 ν(C–O) Sn, 1212 ν(C–O), 566 ν(Sn–O)/ν(Sn–C).
1H NMR (MeOD, ppm): δ 6.35–6.95 (m, 2H, Ar-H), δ 8.21 (s, 1H, phenolic –OH), δ 0.88–1.59 (m, 18 H, Sn–C4H9).
2.2.4 [Bu2Sn(Hhbgl)2] (4)
Complex 4 was prepared in the similar way as complex 1 using dibutyltin(IV) diisopropoxide (1.754 g, 0.005 mol) and H2hbgl (2.135 g, 0.009 mol).
Yield: 2.195 g; colour: dark brown; m.p. >300 °C; Molar conductance: 18 μS cm−1; elemental analysis calculated for C34H54N2O6Sn: C 57.83%, H 7.65%, N 3.97%, Sn 16.82%; Found: C 57.86%, H 7.68%, N 3.94%, Sn 16.86%; Isopropanol in azeotrope calculated: 0.598 g; Found: 0.538 g.
IR (νmax, cm−1; in KBr): 3416 ν(OH); 2958, 2865 νas(C–H)/νs(C–H); 1605 νas(COO); 1413 νs(COO); Δν: 192; 1088, 1034 ν(C–O) Sn; 566 ν(Sn–O)/ν(Sn–C);
1H NMR (MeOD, ppm): δ 6.99 (d, 2H, J = 8.4 Hz, Ar–H), δ 6.92 (d, 2H, J = 8.2 Hz, Ar–H), δ 8.10 (s, 2H, phenolic –OH), δ 5.42 (br, 2H, –NH), δ 0.88, δ 1.03–1.59 (t, m, 18 H, Sn–C4H9).
2.2.5 [Me2Sn(OPri)(Hhbgl)] (5)
The solution of dimethyltin(IV) diisopropoxide (1.334 g, 0.005 mol) and H2hbgl (1.067 g, 0.0045 mol) was refluxed in toluene (30 ml) for 15–16 h at 95–100°. The complex, [Me2Sn(OPri)(Hhbgl)], isolated as a yellow brown solid, was purified by recrystallization from alcohol at room temperature and dried under reduced pressure.
Yield: 1.329 g; colour: light yellow; m.p. >300 °C; Molar conductance: 55 μS cm−1; elemental analysis calculated for (C18H31NO4Sn): C 48.68%, H 6.99%, N 3.16%, Sn 26.75%; Found: C 48.72%, H 7.05%, N 3.10%, Sn 26.80%; Isopropanol in azeotrope calculated: 0.299 g; Found: 0.271 g.
IR (νmax, cm−1; in KBr): 3432 ν(OH), 2961, 2876 νas(C–H)/νs(C–H), 1638 νas(COO), 1408 νs(COO), Δν: 230, 1076 ν(C–O) Sn; 1212 ν(C–O), 571, 549 νas(Sn–C)/νs(Sn–C), 558 ν(Sn–O), 443 ν(N → Sn).
1H NMR (MeOD, ppm): δ 6.59 (d, 1H, J = 8.2 Hz, Ar–H), δ 7.01 (d, 1H, J = 7.9 Hz, Ar–H), δ 7.80 (s, 1H, phenolic –OH), δ 6.5 (br, 1H, –NH), δ 0.52–0.84 (s, 6H, Sn–CH3, 2J 117/119Sn–H = 96 Hz)
2.2.6 [Me2Sn(Hhbgl)2] (6)
Complex 6 was prepared in the similar way as complex 5 using dimethyltin(IV) diisopropoxide (1.334 g, 0.005 mol) and H2hbgl (2.135 g, 0.009 mol).
Yield: 1.898 g; colour: dark brown; m.p. >300 °C; Molar conductance: 45 μS cm−1; elemental analysis calculated for C28H42N2O6Sn: C 54.13%, H 6.77%, N 4.51%, Sn 19.12%; Found: C 54.18%, H 6.82%, N 4.46%, Sn 19.17%; Isopropanol in azeotrope calculated: 0.598 g; Found: 0.540 g.
IR (νmax, cm−1; in KBr): 3419 ν(OH), 2960, 2864 νas(C–H)/νs(C–H), 1632 νas(COO), 1409 νs(COO), Δν: 223, 1052 ν(C–O) Sn; 1221 ν(C–O), 547, 520 νas(Sn–C)/νs(Sn–C), 557 ν(Sn–O), 445 ν(N → Sn).
1H NMR (MeOD, ppm): δ 6.96 (d, 2H, J = 7.5 Hz, Ar–H), δ 6.57 (d, 2H, J = 8.4 Hz, Ar–H), δ 8.06 (s, 1H, phenolic –OH), δ 8.50 (s, 1H, phenolic –OH), δ 1.17 (d, 6H, J = 6.6 Hz, –CH(CH3)2), δ 1.07 (d, 6H, J = 6.9 Hz, –CH(CH3)2), δ 0.46 (s, 6H, Sn–CH3, 2J 117/119Sn–H = 105 Hz).
2.3 Antimicrobial assay
2.3.1 Antibacterial activity
The diorganotin(IV) complexes were screened for their antibacterial activity against four bacterial strains Staphylococcus aureus, Bacillus subtilis, Escherichia coli and Pseudomonas aeruginosa, using the agar well diffusion method. All the microbial cultures were adjusted to 0.5 McFarland standards, which are visually comparable to a microbial suspension of approximately 1.5 × 108 cfu/ml. 20 ml of the Mueller Hinton agar medium was poured into each Petri plate and plates were swabbed with 100 μl inocula of the test microorganisms and kept for 15 min for adsorption. Using sterile cork borer of 8 mm diameter, wells were bored into the seeded agar plates and these were loaded with a 100 μl volume with concentration of 2.0 mg/ml of each compound reconstituted in the dimethylsulphoxide (DMSO). All the plates were incubated at 37 °C for 24 h. Antibacterial activity of each synthetic compound was evaluated by measuring the zone of growth inhibition against the test organisms with a zone reader (HiAntibiotic zone scale). DMSO was used as a negative control whereas Ciprofloxacin was used as a positive control. This procedure was performed in three replicate plates for each organism (Aneja et al., 2011).
2.3.2 Determination of minimum inhibitory concentration (MIC) of chemical compounds
MIC of various complexes against bacterial strains was determined by a modified agar well diffusion method (Aneja et al., 2011). In this method, a twofold serial dilution of each chemically synthesized complex was prepared by first reconstituting the complex in DMSO followed by dilution in sterile distilled water to achieve a decreasing concentration range of 512–1 μg/ml. A 100 μl volume of each dilution was introduced into wells (in triplicate) in the agar plates already seeded with 100 μl of standardized inoculum (106 cfu/ml) of the test microbial strain. All test plates were incubated aerobically at 37 °C for 24 h and observed for the inhibition zones. MIC, taken as the lowest concentration of the chemical compound that completely inhibited the growth of the microbe, showed by a clear zone of inhibition, was recorded for each test organism. Ciprofloxacin was used as the positive control while DMSO as the negative control.
2.3.3 Antifungal activity
The antifungal activity of chemical compounds was evaluated by the poisoned food technique.
The 15 ml of molten SDA (45 °C) was poisoned by the addition of 100 μl volume of each diorganotin(IV) complex having concentration of 2.00 mg/ml, reconstituted in the DMSO, poured into a sterile Petri plate and allowed it to solidify in the laminar flow at room temperature. A fungal plug (8 mm diameter), from the stock of different fungal strains, was inoculated at the centre of the solidified poisoned agar plates in the laminar air flow with a sterile inoculating needle. The inoculated agar slants were then incubated further at 25 °C for 7 consecutive days and were daily checked. DMSO was used as the negative control whereas; Fluconazole was used as the positive control. The experiments were performed in triplicates. Diameter of fungal colonies was measured and expressed as percent mycelial inhibition by applying the formula (Al-Burtamani et al., 2005)
dc = average diameter of fungal colony in negative control sets,
dt = average diameter fungal colony in experimental sets.
3 Result and discussion
3.1 Chemistry
The ligand of thymol derivative was prepared by adopting the earlier reported method (Kumar et al., 1974). The synthetic route used to synthesize ligand and their complexes is outlined in Schemes 1 and 2 respectively. The diorganotin isopropoxides were isolated and reacted to ligand. These reactions proceed with the liberation of isopropanol, which were fractionated out azeotropically and estimated to monitor the completion of reaction. Owing to highly hydroscopic nature of the diorganotin(IV) alkoxides, all the reactions were carried out under strictly anhydrous condition. Various complexes, thus prepared, isolated as coloured solids, were suitably purified.
Synthesis of ligand.

Synthesis of complexes.
3.1.1 Elemental analysis
Analytical data were in good agreement with the proposed stoichiometry of the diorganotin(IV) complexes.
3.1.2 Molar conductance
Molar conductance of the synthesized complexes showed very low values, indicating their non-electrolytic nature (Jamil et al., 2010).
3.1.3 Infrared spectra
IR spectra of the diorganotin complexes displayed a broad band at 3405 (1), 3406 (2), 3417 (3), 3416 (4), 3432 (5), and 3419 (6) cm−1 (Singh, 1985; Abdellah et al., 2009), which were assignable to the unbonded –OH stretching of the phenolic group. The bridging carboxylates in organotin complexes were simply characterized by infrared spectroscopy by the shift of ν(COO) bands, as compared with the parent ligand. The magnitude of Δν [νas − νs] was used to determine the coordination status of the carboxylate group (Sandhu and Verma, 1987; Deacon and Phillips, 1980). In infrared spectra of [Ph2Sn(OPri)(Hhbgl)] (1), [Ph2Sn(Hhbgl)2] (2), [Bu2Sn(OPri)(Hhbgl)] (3), [Bu2Sn(Hhbgl)2] (4), [Me2Sn(OPri)(Hhbgl)] (5) and [Me2Sn(Hhbgl)2] (6), the asymmetric stretching frequencies νas(COO) and symmetric stretching frequencies νs(COO) appeared at 1639, 1416; 1639, 1413; 1602, 1412; 1605, 1413; 1638, 1408; 1632, and 1409 cm−1 respectively. The magnitude of νas − νs (Δν) for 1, 2, 5 and 6 were above 200 cm−1, indicating the unidentate bonding of the carboxylate group to the tin atom (Fig. 1). While, for the complexes 3 and 4, the values of Δν were below 200 cm−1, this clearly demonstrated that these complexes adopted the bidentate carboxylate structure (Fig. 1). A medium peak at 550–570 cm−1 was assignable to the Sn–O stretching frequency, which further confirmed the bonding of the carboxylate group to the tin atom (Nath and Yadav, 1998, 1997). The proposed coordination of the diphenyl- and dimethyltin(IV) complexes was further supported by the appearance of a band in the region of 441–456 cm−1 due to the ν(N → Sn) (Nath et al. 2003). The far IR spectra of diphenyltin(IV) complexes showed Sn–C stretching vibrations, νas(Sn–C) and νs(Sn–C) bands at 269–281 cm−1 and at 225 ± 3 cm−1, respectively, as reported in the literature (Nath et al., 2001; Nath and Saini, 2011), whereas the corresponding peaks at 559 ± 12 and at 535 ± 15 cm−1, (Nath et al., 2001) have also been assigned in the spectra of dimethyltin(IV) complexes. While in dibutyltin(IV) complexes the appearance of Sn–C stretching bands was not certain due to overlapping with the Sn–O stretching vibrations.
Proposed structure of diorganotin(IV) complexes.
3.1.4 1HNMR spectroscopy
1HNMR data for the synthesized complexes and ligand in DMSO and MeOD solutions are given in the experimental section. 1H NMR spectra of the complexes, displayed signals in the region of δ 7.80–8.50 ppm which may be attributed to the unbonded phenolic group proton (Williams and Fleming 2004). In the complex 1 and 2, the signals for the phenyl group attached to tin were observed in the range of δ 6.58–7.86 ppm, in conjugation with phenyl protons of the ligand. 1H NMR spectra of the dibutyltin(IV) complexes showed the triplet at δ 0.88 ppm and multiplets in the range of δ 0.88–1.59 ppm (Matela and Aman, 2012; Nath et al., 1997; Shahzadi et al., 2008) due to butyl protons attached to the tin atom. The 2J (117/119Sn–C–1H) value was only observed in the spectrum of the dimethyltin(IV) complexes. The estimated value of C–Sn–C bond angle, in complex 6, was found to be 154° by substituting 2J (117/119Sn–C–H) value in the Lockhart equation (Lockhart and Manders, 1986), indicating an octahedral geometry (Torres et al., 2011). While the value of coupling constant 2J (117/119Sn–C–H) for the complex 5, in MeOD, was found to be 96 Hz, indicating five-coordination (Casas et al., 2003).
3.2 Antimicrobial evaluation
3.2.1 Antibacterial activity
The antibacterial activity result is presented in Tables 1 and 2, respectively. These results show that diorganotin(IV) complexes possessed a variable antibacterial activity against both Gram-positive and Gram negative bacteria. Complexes namely, 1 and 2 showed the highest zone of inhibition of 28.3 mm and 29.6 mm against S. aureus which is more than the standard antibiotic used in this study, while complex 5 showed the zone of inhibition of 26.6 mm against B. subtilis which was equal to the standard antibiotic used in this study. However in case of Gram negative bacteria, two complexes, 2 and 5 were found to be most effective against E. coli with the zone of inhibition 21.3 and 21.6 mm, respectively and complex 5 against P. aeruginosa with the zone of inhibition 20.3 mm (Table 1). Thus it has been shown that the diorganotin(IV) complexes showed a higher activity against Gram positive bacteria as compared to Gram negative bacteria.
| Compound No. | Diameter of growth of inhibition zone (mm)a | |||
|---|---|---|---|---|
| Staphylococcus aureus | Bacillus subtilis | Escherichia coli | Pseudomonas aeruginosa | |
| 1 | 28.3 | 22.3 | 19.6 | 17.6 |
| 2 | 29.6 | 24.6 | 21.3 | 18.3 |
| 3 | 22.6 | 21.0 | 18.3 | 15.6 |
| 4 | 23.3 | 22.3 | 20.6 | 16.3 |
| 5 | 22.3 | 26.6 | 21.6 | 20.3 |
| 6 | 22.6 | 24.3 | 20.3 | 18.6 |
| Ciprofloxacin | 27.6 | 26.3 | 25.0 | 25.3 |
| Compound No. | MIC (μg/ml) | |||
|---|---|---|---|---|
| Staphylococcus aureus | Bacillus subtilis | Escherichia coli | Pseudomonas aeruginosa | |
| 1 | 4 | 16 | 64 | 64 |
| 2 | 4 | 16 | 32 | 64 |
| 3 | 32 | 16 | 64 | 128 |
| 4 | 32 | 16 | 64 | 128 |
| 5 | 32 | 8 | 32 | 64 |
| 6 | 32 | 16 | 64 | 64 |
| Ciprofloxacin | 5 | 5 | 5 | 5 |
In the whole series, the MIC of diorganotin(IV) complexes ranged between 4 and 32 μg/ml against Gram positive bacteria and 128 and 32 μg/ml against Gram negative bacteria, respectively. Complexes 1 and 2 were found to be the best as they exhibit the lowest MIC of 4 μg/ml against S. aureus and complex 5 against B. subtilis with the lowest MIC of 8 μg/ml. In case of Gram negative bacteria, complexes 2 and 5 showed the lowest MIC of 32 μg/ml against E. coli, whereas diorganotin(IV) complexes were found to be exhibit very low activity against P. aeruginosa (Table 2). Comparison of MIC of organotin complexes with standard antibiotic, ciprofloxacin is represented in Fig. 2.
Comparison of MIC (μg/ml) of synthesized complexes with standard antibiotic. C, ciprofloxacin.
3.2.2 Antifungal activity
In case of fungal strains four complexes 1, 2, 4 and 5 showed more than 60% inhibition of mycelial growth against A. niger and Penicillium sp. whereas only one complex 5 showed more than 60% inhibition of mycelial growth against Aspergillus flavus (Table 3). Comparison of antifungal activity of newly synthesized complexes with a standard drug fluconazole against the tested fungal strains in terms of % mycelial growth inhibition is shown in Fig. 3.
| Compound No. | Mycelial growth inhibition (%) | ||
|---|---|---|---|
| Aspergillus niger | Aspergillus flavus | Penicillium sp. | |
| 1 | 64.4 | 58.8 | 66.6 |
| 2 | 62.5 | 54.4 | 63.3 |
| 3 | 53.3 | 47.7 | 51.1 |
| 4 | 61.1 | 55.5 | 62.5 |
| 5 | 65.5 | 61.1 | 62.5 |
| 6 | 55.5 | 50 | 53.3 |
| Fluconazole | 81.1 | 77.7 | 83.3 |

- Comparison of (%) mycelial growth inhibition of complexes with standard antifungal drug. F, fluconazole.
4 Conclusions
In the light of above finding penta-, and hexa-coordinate geometry are proposed for diorganotin(IV) complexes. In diphenyl- and dimethyltin(IV) complexes, monodentate bonding of the carboxylate group is observed, while dibutyltin(IV) complexes adopted the bidentate carboxylate structure.
The in vitro antimicrobial activity against bacteria and fungi was evaluated. The bioassay results revealed that the diphenyltin(IV) complex, in general, exhibits a greater antimicrobial activity than dibutyl-, and dimethytin(IV) complexes. In general, the order of antimicrobial activity of diorganotin(IV) complexes is Ph > Me > Bu.
Acknowledgements
One of the authors (R.A.) thanks the U-COST, Dehradun, UK, for financial support in the form of a Research Project and another of the authors (G.M.) for the award of Project Fellowship under the same project.
References
- Organometallic compounds in oncology: implications of novel organotins as antitumor agents. Drug Discov. Today. 2009;14:500-508.
- [Google Scholar]
- Chemical composition, antibacterial and antifungal activities of the essential oil of Haplophyllum tuberculatum from Oman. J. Ethnopharmocol.. 2005;96:107-112.
- [Google Scholar]
- Di- and triorganotin(IV) carboxylates derived from triorganotin(IV) iodide with mixed organic groups on tin: cyclic, hexameric triorganotin(IV) carboxylates. Inorg. Chim. Acta. 2009;362:355-360.
- [Google Scholar]
- Synthesis, characterization, and molecular structures of di- and triorganotin(IV) complexes with 9-anthracenecarboxylic acid: the structural diversity in organotin 9-anthracenecarboxylates. J. Organomet. Chem.. 2007;692:3922-3930.
- [Google Scholar]
- In vitro efficacy of amaltas (Cassia fistula L.) against the pathogens causing otitis externa. Jundishapur J. Microbiol.. 2011;4:175-183.
- [Google Scholar]
- Synthesis, characterization, and biological studies of organotin(IV) derivatives with o- or p-hydroxybenzoic acids. Bioinorg. Chem. Appl. 2009 10.1155/2009/542979
- [Google Scholar]
- Synthesis and structural characterization of diorganotin(IV) complexes with 2,6-pyridinedicarboxylic acid. Appl. Organometal. Chem.. 2008;22(1):19-24.
- [Google Scholar]
- Diorganotin(IV)-promoted deamination of amino acids by pyridoxal: SnR2+2 complexes of pyridoxal 5′-phosphate and of the Schiff base pyridoxal-pyridoxamine (PLPM), and antibacterial activities of PLPM and [SnR2 (PLPM-2H)] (R = Me, Et, Bu, Ph) Polyhedron. 2003;22:53-65.
- [Google Scholar]
- Synthesis, structure and cytotoxicity studies on diorganotin (R = Me, Et) complexes of N-methylpyridoxine (MePN, PN = Vitamin B6) containing different anions. J. Organomet. Chem.. 2008;696:4236-4247.
- [Google Scholar]
- Relationships between the carbon–oxygen stretching frequencies of carboxylato complexes and the type of carboxylate coordination. Coord. Chem. Rev.. 1980;33:227-250.
- [Google Scholar]
- Organotin meclofenamic complexes: synthesis, crystal structures and antiproliferative activity of the first complexes of meclofenamic acid – novel anti-tuberculosis agents. J. Inorg. Biochem.. 2009;103(5):738-744.
- [Google Scholar]
- Biologically active organotin(IV) Schiff Base Complexes. J. Iran. Chem. Soc.. 2010;7:495-499.
- [Google Scholar]
- Mannich reactions. N-[2-hydroxy-3 (or 5 or 6)-substituted] benzyl glycines. J. Ind. Chem. Soc.. 1974;51:944-946.
- [Google Scholar]
- Diorganotin(IV) complexes with 2-benzoylpyridine and 2-acetylpyrazine N(4)-phenylthiosemicarbazones: synthesis, crystal structures and biological activities. J. Organomet. Chem.. 2011;696(4):852-858.
- [Google Scholar]
- Structural determination by NMR spectroscopy. dependence of [2J (119Sn, 1H)] on the Me–Sn–Me angle in methyltin (IV) compounds. Inorg. Chem.. 1986;25:892-895.
- [Google Scholar]
- Organotin(IV) complexes of carboxylic acid derivatives. Cent. Eur. J. Chem.. 2012;10:1-15.
- [Google Scholar]
- Reactions of tin- and triorganotin(IV) isopropoxides with thymol derivative: synthesis, characterization and in vitro antimicrobial screening. J. Serb. Chem. Soc.. 2013;78(9):1323-1333.
- [Google Scholar]
- Synthesis, structures, 119Sn Mössbauer spectroscopic studies and biological activity of some tin(IV) complexes containing pyridyl functionalised selenosemicarbazonato ligands. J. Organomet. Chem.. 2012;701:80-86.
- [Google Scholar]
- Chemistry and applications of organotin(IV) complexes of Schiff bases. Dalton Trans.. 2011;40:7077-7121.
- [Google Scholar]
- Comparative study of structure–activity relationship of di- and tri-organotin(IV) derivatives of amino acid and peptides. J. Organomet. Chem.. 2003;669:109-123.
- [Google Scholar]
- Organotin(IV) complexes of amino acids and Peptides. Coord. Chem. Rev.. 2001;215:99-149.
- [Google Scholar]
- Spectral studies and in vitro antimicrobial activity of new organotin(IV) complexes of Schiff bases derived from amino acids. Bull. Chem. Soc. Jpn.. 1997;70:1331-1337.
- [Google Scholar]
- Studies of organotin(IV) derivatives of dl-methionine and l-aspragine. Bull. Chem. Soc. Jpn.. 1998;71:1355-1362.
- [Google Scholar]
- Synthesis, characteristic spectral studies and in vitro antimicrobial and antitumour activities of organotin(IV) complexes of Schiff bases derived from amino-acids. Appl. Organomet. Chem.. 1997;11(9):727-736.
- [Google Scholar]
- Synthesis, characterization, and biocidal studies of the newly synthesized di- and triorganotin(iv) complexes with n-butylhydrogen phthalate turk. J. Chem.. 2007;31:371-387.
- [Google Scholar]
- Triorganotin(IV) derivatives of five membered heterocyclic 2-carboxylic acids. Polyhedron. 1987;6(3):587-591.
- [Google Scholar]
- Cobalt(II), nickel(II) and copper(II) complexes of Schiff bases derived from aminoacids and acetylacetone. Synt. React. Inorg. Met. Org. Chem.. 1985;15(2):235-246.
- [Google Scholar]
- Some bioactive organotin(IV) derivatives with 3,4-dichlorophenylacetic acid: synthesis, spectroscopic properties, and X-ray structure of [Sn4(C4H9)8 (OOCCH2C6H3Cl2)4O2] Turk. J. Chem.. 2010;34:109.
- [Google Scholar]
- Synthesis, spectral characterization and crystal structure of a novel trinuclear di-n-butyltin(IV) complex with pyruvic acid-N(4)-cyclohexylthiosemicarbazone (H2PACT) J. Organomet. Chem.. 2012;69:4202-4206.
- [Google Scholar]
- Synthesis, crystal structures, electrochemical studies and anti-tumor activities of three polynuclear organotin(IV) carboxylates containing ferrocenyl moiety. J. Organomet. Chem.. 2011;696:3180-3185.
- [Google Scholar]
- Characterization and antimicrobial activity of organotin(IV) complexes of 2-[(2′,6′-diethylphenylamido)]benzoates and 3-[(2′,6′-diethylphenylamido)] propanoates. Turk. J. Chem.. 2008;32:333-353.
- [Google Scholar]
- Chemistry of tin (2nd ed.). London: Blackie Academic and Professional; 1997.
- Antimicrobial activity of organotin(IV) complexes with the ligand benzyl bis(benzoylhydrazone) and 4,4′-bipyridyl as coligand. J. Inorg. Biochem.. 2011;105:600-608.
- [Google Scholar]
- Luminescent organotin complexes with the ligand benzil bis(benzoylhydrazone) J. Organomet. Chem.. 2010;695:2305-2310.
- [Google Scholar]
- Spectroscopic Methods in Organic Chemistry. Tata McGraw-Hill; 2004. p. :161. 5th ed.
